Literature DB >> 28294498

Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.

J Brown1,2, J A McGowan3, H Chouial4, S Capocci1,2, C Smith3, D Ivens4, M Johnson4, L Sathia4, R Shah4, F C Lampe3, A Rodger3,4, M Lipman1,2.   

Abstract

OBJECTIVES: We sought to evaluate whether people living with HIV (PLWH) using effective antiretroviral therapy (ART) have worse respiratory health status than similar HIV-negative individuals.
METHODS: We recruited 197 HIV-positive and 93 HIV-negative adults from HIV and sexual health clinics. They completed a questionnaire regarding risk factors for respiratory illness. Respiratory health status was assessed using the St George's Respiratory Questionnaire (SGRQ) and the Medical Research Council (MRC) breathlessness scale. Subjects underwent spirometry without bronchodilation.
RESULTS: PLWH had worse respiratory health status: the median SGRQ Total score was 12 [interquartile range (IQR) 6-25] in HIV-positive subjects vs. 6 (IQR 2-14) in HIV-negative subjects (P < 0.001); breathlessness was common in the HIV-positive group, where 47% compared with 24% had an MRC breathlessness score ≥ 2 (P = 0.001). Eighteen (11%) HIV-positive and seven (9%) HIV-negative participants had airflow obstruction. In multivariable analyses (adjusted for age, gender, smoking, body mass index and depression), HIV infection remained associated with higher SGRQ and MRC scores, with an adjusted fold-change in SGRQ Total score of 1.54 [95% confidence interval (CI) 1.14-2.09; P = 0.005] and adjusted odds ratio of having an MRC score of ≥ 2 of 2.45 (95% CI 1.15-5.20; P = 0.02). Similar findings were obtained when analyses were repeated including only HIV-positive participants with a viral load < 40 HIV-1 RNA copies/mL.
CONCLUSIONS: Despite effective ART, impaired respiratory health appears more common in HIV-positive adults, and has a significant impact on health-related quality of life.
© 2017 The Authors HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.

Entities:  

Keywords:  lung; patient reported outcome; quality of life; respiratory; smoking

Mesh:

Substances:

Year:  2017        PMID: 28294498     DOI: 10.1111/hiv.12497

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  4 in total

Review 1.  Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.

Authors:  Meghan E Fitzpatrick; Ken M Kunisaki; Alison Morris
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

Review 2.  Chronic obstructive pulmonary disease in HIV.

Authors:  Katerina Byanova; Ken M Kunisaki; Joshua Vasquez; Laurence Huang
Journal:  Expert Rev Respir Med       Date:  2020-11-23       Impact factor: 3.772

3.  HIV infection is an independent risk factor for decreased 6-minute walk test distance.

Authors:  Tom E Robertson; Mehdi Nouraie; Shulin Qin; Kristina A Crothers; Cathy J Kessinger; Deborah McMahon; Divay Chandra; Lawrence A Kingsley; Ruth M Greenblatt; Laurence Huang; Meghan E Fitzpatrick; Alison Morris
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

4.  The effect of HIV status on the frequency and severity of acute respiratory illness.

Authors:  James Brown; Elisha Pickett; Colette Smith; Memory Sachikonye; Lucy Brooks; Tabitha Mahungu; David M Lowe; Sara Madge; Mike Youle; Margaret Johnson; John R Hurst; Timothy D McHugh; Ibrahim Abubakar; Marc Lipman
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.